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Model membranesActinoporins are pore-forming toxins produced by different sea anemones that self-assemble within
the membranes of their target cells and compromise their function as a permeability barrier. The
recently published three-dimensional structures of two oligomeric complexes formed by fra-
gaceatoxin C point to Val60 as a key residue involved in the oligomerization of the functional pore.
To gain insight into the mechanism of toxin oligomerization, different point mutations have been
introduced at this position. Functional characterization of the muteins suggests that Val60 repre-
sents a hot-spot where the introduction of mutations hinders protein assembly and reduces the
overall afﬁnity for membranes.
 2015 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
The lytic mechanism of a wide variety of pore-forming toxins
(PFT) involves an oligomerization step that leads to the assembly
of the fully functional pore. Oligomerization can be induced by
binding to other molecules [1] or by environmental factors such
as ﬂuctuations in pH [2], temperature [3], or hydrophobicity [4].
Actinoporins are a well-known example of membrane-induced
oligomerization, since the presence of a lipid bilayer is strictly nec-
essary to trigger the construction of the active pore [5].In oligomeric PFT, the protomers are held together mainly by
electrostatic forces, as in Vibrio cholerae cytolysin (VCC) [6] or
Staphylococcus aureus a- and c-hemolysins [7,8], although
non-polar interactions have also been described for the so-called
latch structure described in S. aureus hemolysins, where isoleucine
and valine residues interact at the protomer–protomer interface
[4,7].
Recently, the three-dimensional structures of two oligomeric
complexes formed by fragaceatoxin C (FraC), an actinoporin from
the sea anemone Actinia fragacea, have been reported (PDB codes:
3LIM and 4TSY) [5,9]. In both structures, the interface between
adjacent subunits exhibits high shape complementarity and
resembles a mortise-and-tenon joint, where Val60 from one pro-
tomer protrudes into a cavity within the opposing protomer lined
by two (4TSY) or three (3LIM) aromatic residues, namely Phe16,
Trp149 and Phe163 (Fig. 1A) [5,9]. Curiously, Val60 is one of the
residues with highest buried surface area (95.5 ± 1.2 Å2) and estab-
lishes a number of contacts with the residues lining the aromatic
cavity [5]. Moreover, Val60 is a highly conserved residue within
actinoporins (Fig. 1B). These features strongly suggest a key role
Fig. 1. Protomer–protomer interface in the membrane-inserted oligomeric FraC pore. (A) Val60 (red) from one protomer (green) protrudes into an aromatic pocket in the
adjacent subunit (cyan). The aromatic cavity is lined by residues Trp149 and Phe163. The complete octameric pore is shown in the inset (PDB entry 4TSY). (B) Multiple
sequence alignment of actinoporins with known crystal structure. The residue at position 60 is depicted in red. The alignment was performed with CLUSTALW2 and shaded
with BoxShade.
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of choice to further examine the oligomerization step that takes
place during the mechanism of pore formation by FraC.
For this purpose, we introduced several point mutations at posi-
tion 60 in order to determine how these changes affected the activ-
ity of FraC. Val60 was replaced by arginine (V60R), lysine (V60K),
glutamic acid (V60E) or phenylalanine (V60F). Amino acids Arg,
Lys, and Glu were expected to introduce polar–apolar repulsions
within the adjacent aromatic pocket, whereas Phe was expected
to alter the shape complementarity between adjacent protomers.
Functional data based on experiments carried out on red blood
cells (RBC) or model membranes conﬁrmed the relevance of Val60
in mediating proteomer–protomer interactions for the correct
assembly of FraC subunits, a key step leading to the formation of
the functional pore.
2. Materials and methods
2.1. Protein expression and puriﬁcation
Expression and puriﬁcation of monomeric FraC was carried out
as previously described [10], with minor modiﬁcations. Growth
and expression were induced by 0.5 mM IPTG for 20 h at 20 C.
The protein was then puriﬁed to homogeneity in two chromato-
graphic steps involving a Resource S cationic-exchange column
(GE Healthcare, Piscataway, NJ, USA) and a HiLoad 16/60
Superdex 75 prep grade column (GE Healthcare, UK).
Site-directed mutagenesis to generate the various muteins was
carried out as in [11].
2.2. Hemolytic activity measurements
Deﬁbrinated sheep blood (Pronadisa, Madrid, Spain) was
washed in 5 mM sodium phosphate buffer, 150 mM NaCl, pH 8.
After incubation of a ﬁxed concentration of RBC (3  106 cells/ml)
with a variable concentration of protein in a 96-well plate for90 min at room temperature, the total hemoglobin released from
the cells was measured as A412. The percentage of hemolysis was
then calculated as:
Hemolysis ð%Þ ¼ ðAmax  AfinÞ=ðAmax  AminÞ  100
where Aﬁn corresponds to the ﬁnal absorbance measured for each
well. Amax and Amin represent the A412 values for 100% and 0%
hemolysis achieved with distilled water and buffer, respectively.
2.3. Liposome preparation
Brain porcine sphingomyelin (SM) and chicken egg L-a-phos-
phatidylcholine (PC) (Avanti Polar Lipids, AL, USA) were dissolved
in chloroform:methanol (2:1, v/v) and evaporated thoroughly. The
dry lipid ﬁlm was resuspended by vortexing in 50 mM NaCl,
10 mM HEPES-NaOH, pH 7.5 containing 25 mM 8-aminonaphthale
ne-1,3,6-trisulfonic acid (the ﬂuorophore) and 90 mM p-xyle-
ne-bis-pyridinium bromide (the quencher) (Molecular Probes, OR,
USA) to yield multilamellar vesicles that subsequently were sub-
jected to 10 cycles of freeze–thaw as previously described [10].
Large unilamellar vesicles (LUV) were prepared by extrusion
through polycarbonate ﬁlters with a pore diameter of 0.1 lm
(Nucleopore, Pleasanton, CA, USA) [12]. Non-encapsulated ﬂuores-
cent probes were separated from the vesicle suspension through a
Sephadex G-25 column (Amersham Biosciences, GE Healthcare,
UK) eluted with isosmotic 10 mM HEPES-NaOH, 200 mM NaCl, pH
7.5. Phospholipid concentration was measured according to
Bartlett [13].
2.4. Leakage of encapsulated solutes
The leakage of encapsulated solutes was assayed as described
by Ellens [14]. Brieﬂy, the ﬂuorescence of LUV suspensions
(0.1 mM) treated with FraC (0.67 lM) was followed with excitation
and emission wavelengths set at 355 nm and 515 nm, respectively.
An absorption ﬁlter of 475 nm was placed between the sample and
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probe was achieved by the addition of Triton X-100 (ﬁnal concen-
tration 0.1% w/v). The percentage of leakage was calculated as
follows:
% Leakage ¼ ðFf  F0=F100  F0Þ  100
where Ff is the ﬂuorescence measured after addition of the toxin, F0
is the initial ﬂuorescence of the liposome suspension and F100 is the
ﬂuorescence after addition of detergent. Measurements were car-
ried out at room temperature with constant stirring in a
FluoroMax-3 spectroﬂuorometer (Horiba Jobin Yvon, Kyoto, Japan).2.5. Puriﬁcation of oligomeric FraC
Toxins (100 lM) were incubated with LUVs (200:1 lipid:protein
molar ratio) in 50 mM Tris–HCl, 200 mM NaCl pH 7.4 buffer (SEC
buffer) for 30 min at room temperature. The proteo-liposome com-
plex was solubilized by adding Triton X-100 to the mixture at a
ﬁnal concentration of 1% (v:v). The sample (approximately 500 ll
in volume) was then diluted 20-fold in 50 mM Tris–HCl, 0.3 mM
DDM pH 7.4 (buffer A) and applied to a Resource S
cationic-exchange column. To elute the protein, a linear salt gradi-
ent was formed by mixing buffer A with 50 mM Tris–HCl, 1 M NaCl,
0.3 mM DDM pH 7.4 (buffer B). Fractions were then analyzed by
size-exclusion chromatography in a Superdex 200 10/300 GL col-
umn equilibrated with SEC buffer supplemented with 0.3 mM
DDM. The presence of protein in the elution peaks was veriﬁed
by SDS–PAGE.2.6. Surface pressure measurements
Surface pressure measurements were carried out by the
Wilhelmy plate method [15] using a Micro-Trough-S system from
Kibron (Helsinki, Finland) at room temperature with constant stir-
ring. In this method, the tip of a titanium probe connected to an
electrobalance is submerged in an aqueous solution. At the air–wa-
ter interface, the surface tension of the water molecules exerts a
downward force on the probe which is registered by the elec-
trobalance. The displacement of water molecules from the air–wa-
ter interface by amphiphilic molecules injected in the aqueous
subphase results in changes in the weight of the probe that are
monitored and recorded. Surface tension measurements are read-
ily converted to surface pressure values (p) by subtracting the sur-
face tension of the sample from that of the pure solvent, which in
the case of water is 72.8 mN/m.
The aqueous subphase consisted of 1 ml of 10 mM
HEPES-NaOH, 200 mM NaCl, pH 7.5. A lipid mixture containing
the adequate proportions of SM and PC dissolved in chloro-
form/methanol (2:1, v/v), was gently spread over the air–water
interface. The desired initial surface pressure was attained by
applying different amounts of lipid. After 10 min (to allow for sol-
vent evaporation) the protein was injected into the subphase at a
ﬁnal concentration of 1 lM and the resulting increment in surface
pressure (Dp) recorded. To calculate the surface pressure after
maximum insertion, a three-parameter rectangular hyperbola
[16] was ﬁtted to the kinetic data:
y ¼ y0 þ ða  x=bþ xÞ
where y is Dp, y0 is the initial surface pressure (p0), a is the maxi-
mum surface pressure achieved and b is a constant that represents
the time necessary to reach half of the maximum increase. The crit-
ical pressure (pc) was obtained by solving the above equation when
y = 0.2.7. Thermal stability by circular dichroism (CD)
Thermal denaturation was monitored using a J-820 spectropo-
larimeter (Tokyo, Japan) equipped with a Jasco PTC-423L tempera-
ture controller in 1 mm quartz cuvettes. Unfolding of the toxins in
20 mM Tris–HCl pH 8 was monitored at 210 nm using a heating
rate of 1 C/min and a 2 nm band-width. Denaturation tempera-
tures (TM) were calculated by ﬁtting a two-state model equation
to the experimental data [17]:
Protein unfolding ð%Þ ¼ ½k=ð1þ kÞ100
where k is the folding constant and is expressed as:
k ¼ exp½ðDH=ð1:987TÞÞ  ððT=TMÞ  1Þ
where TM is the temperature at which the protein is 50% unfolded,
DH is the change in enthalpy, and T is the temperature.
2.8. Isothermal titration calorimetry (ITC)
The interaction between toxins and liposomes was measured
with an ITC200 Micro Calorimeter (GE Healthcare, UK) in SEC buf-
fer at 25 C. The LUV suspension was injected into a cell containing
protein under constant stirring. The heat released after each injec-
tion was determined from the raw data by integration of the indi-
vidual exothermic peaks after subtraction of the baseline. The
model used to ﬁt the binding isotherms considered that a molecule
of protein binds to nmolecules of lipid and is incorporated into the
software ORIGIN 7 as described previously [18]. Each titration was
repeated at least twice.3. Results
3.1. Hemolytic activity and protein stability
The hemolytic potency of the muteins was compared with that
of wild-type FraC (WT). Fig. 2A shows the percentage of hemoglobin
released from RBC treated with the toxins over a broad range of
concentrations. The strongest inhibitory effect was observed with
V60E. The concentration of V60E that causes 50% hemolysis
(HC50) was approximately 30-fold higher than that of WT
(HC50WT = 2.4 ± 0.3 nM; HC50V60E = 67.6 ± 6.9 nM). The hemolytic
activity of the other muteins was also reduced, but to a lesser
extent (HC50V60R = 18.0 ± 4.3 nM; HC50V60K = 13.8 ± 0.7 nM;
HC50
V60F = 16.7 ± 4.1 nM), thus conﬁrming the key role played by
Val60 in protein–protein interactions during pore formation.
The decreased activity could be due to changes in thermal sta-
bility introduced by the various point mutations. To rule out this
possibility, we determined the protein denaturation temperature
(TM) of the different toxins by measuring their molar ellipticities
in a broad temperature range (25–70 C) (Fig. 2B). In all cases,
the unfolding proﬁles were very similar (TMWT = 53.2 C;
TM
V 60E = 54.1 C; TMV 60R = 55.1 C; TMV 60K = 54.8 C; TMV 60F = 51.3 C)
(Fig. 2B) and might not explain the poor hemolytic activity of the
muteins. This is particularly evident in the case of V60E, whose
TM is very to that of the WT but hardly conserves hemolytic
activity.
3.2. Interaction with model membranes
The lytic activity of WT and muteins was measured as the
release of ﬂuorescent contents from LUVs made of SM:PC (1:1)
(Fig. 3A and Table 1). The results correlate well with those
observed in RBCs (Fig. 2A): whereas V60E lacked lytic activity
(0% leakage), the activity of the other muteins was approximately
one third of that of WT (Table 1).
Fig. 2. Biological activity and stability. (A) Percentage of hemolysis as a function of protein concentration. The curves correspond to the best ﬁt to the Hill equation [31]. (B)
Thermal denaturation curves of WT and muteins measured as the percentage of change in ellipticity at 210 nm. A two-state model equation was ﬁtted to the data points (see
Section 2). The color code for each protein is shown in panel A.
K. Morante et al. / FEBS Letters 589 (2015) 1840–1846 1843From the percentage leakage vs. protein concentration range we
estimated the concentration of protein necessary to achieve 50%
lysis (C50) (Fig. 3B and Table 1). The C50 was highest for V60E
(C50 = 4.4 ± 0.26 lM) and lowest for WT (C50 = 0.3 ± 0.01 lM). The
other muteins showed C50 intermediate values close to 1 lM but,
interestingly, the dependence of their permeabilizing activities
on protein concentration was different, as inferred from the slope
of the sigmoid curves. This could be related to a decrease in coop-
erativity that affects in a different way to each mutein and inter-
feres with the oligomerization process.
Next, we carried out size-exclusion chromatographic analysis in
order to determine if oligomers were produced by the different
muteins. Fig. 3C shows the elution proﬁles of WT and the least
active mutein (V60E). In aqueous solution, the elution volumes of
WT and V60E are 27.9 ± 0.1 ml and 27.2 ± 0.1 ml, respectively
and these peaks are attributed to the monomeric species. These
volumes are higher than the column bed volume corresponding
to the column ( 20.5 ml). Most likely, this is due to non-speciﬁc
interactions with the column’s matrix [19]. After incubation of
the vesicles with either toxin, a new peak appears at
12.2 ± 0.1 ml. This peak contains protein as judged by SDS–PAGE
analysis (Fig. 3D) and might correspond to solubilized
membrane-bound oligomers. This peak represents 86% of the total
protein in the case of WT and 19% of the protein in the case of V60E
(Fig. 3C and Table 1). Most of V60E (81%) eluted at 26.22 ± 0.1 ml,
which is consistent with a monomeric species with some bound
lipid and/or detergent molecules [9].
The other muteins showed similar elution proﬁles, although the
distribution between oligomers and monomers was not as extreme
(Supplementary Fig. 1A and Table 1).
The interaction of the toxins with lipid monolayers made of
SM:PC (1:1) was measured by monitoring the Dp induced after
injection of the proteins in the aqueous subphase (Fig. 3E). The crit-
ical pressure parameter (pc) indicates the surface pressure of the
monolayer above which a protein can no longer insert. In biological
membranes, this surface pressure is approximately 30–35 mN/m
[20]. Consequently, proteins with pc below this value would be
unable to insert. The pc value for WT is 36 ± 1.1 mN/m. The critical
pressures for the muteins are slightly lower (pcmuteins  30 mN/m)
but still in the range where they can theoretically insert into a bio-
logical membrane (Fig. 3E, Table 1) [21].
3.3. Calorimetric studies
Isothermal titration calorimetry (ITC) was used for the thermo-
dynamic characterization of the binding of the toxins to LUVs made
of SM:PC (1:1). The binding of WT FraC (Fig. 4A) is enthalpy-driven
(DHWT = 9.9 ± 0.5 kcal mol1) and shows moderate afﬁnity for
lipids (KDWT = 16 ± 9 lM; DG = 6.5 ± 0.3 kcal mol1). Theenthalpic component is partially compensated by the entropic
component (TDS = 3.3 ± 0.8 kcal mol1), as previously described
for sticholysin II and FraC in other lipid mixtures [18,22]. In con-
trast, binding of V60E to liposomes generated a weak exothermic
signal, nor sufﬁcient for a reliable quantiﬁcation of the thermody-
namic parameters (Fig. 4B).
4. Discussion
During evolution proteins have found ways to acquire struc-
tural and/or functional advantages by assembling with other pro-
teins (identical or not) into oligomeric complexes [23]. For
instance, protein oligomerization provides enzymes with an
increased stability or a better regulation of their activity, as high-
lighted by thermostable or allosteric enzymes [24,25].
In actinoporins, oligomerization is a key step for the assembly
of the functional pore. For some decades, important residues
involved in the oligomerization of these toxins have remained elu-
sive. Only residue Lys77 in equinatoxin II has been related to this
process [26]. This scenario changed completely after the crystal
structures of two oligomeric complexes formed by FraC were
solved [5,9]. They form a protein ring where the contact surfaces
involved in protein–protein interactions are rather small
(777 Å2) [9] but exhibit high shape complementarity (0.66) [5],
very close to that of antibody-antigen complexes [27]. Curiously,
Lys77 does not lie within this region [9]. The position of Val60,
however, suggests that this residue is central for the correct assem-
bly of the protomers. Its side chain presents the second highest
buried surface area (95.5 ± 1.2 Å2) because it occupies an aromatic
cavity within the adjacent subunit (Trp149 is the residue with
highest buried surface area: 115.1 ± 5.7 Å2). Point mutations intro-
duced at this position are expected to greatly interfere with the
assembly of the pore.
Of all the residues introduced at position 60 of FraC, only the
glutamic acid showed an almost complete inhibition of lytic activ-
ity. This is not due to impaired binding to the membrane, since its
insertion into lipid monolayers is identical to that of the other
muteins (Fig. 3E). Therefore, the disruption must arise during the
oligomerization step. A further look at the structure of the aromatic
pocket housing Val60 reveals a glutamic acid residue (Glu173)
2.3 Å away from Val60. The slightly longer side chain of V60E
would lie even closer and, most likely, will give rise to an electro-
static repulsion between adjacent protomers. As a consequence,
the population of fully-assembled pores would be greatly reduced
(Fig. 3C), thus leading to a considerably lower lytic activity in RBC
and liposomes (Figs. 2A and 3B).
On the other hand, the positively-charged residues arginine and
lysine at position 60 might establish salt bridges with Glu173 that
result in a 13% reduction in the number of oligomers formed
Fig. 3. Activity and interaction of FraC with model membranes of SM:PC (1:1). (A) Leakage kinetics as measured by the release of encapsulated solutes from LUV. Lipid
concentration was 100 lM and the lipid:protein molar ratio was 150:1. (B) Dependence of solute release on protein concentration. The ﬁnal ﬂuorescence was measured
20 min after protein addition (Table 1). The curves correspond to the best ﬁt to the Hill equation [31]. (C) SEC chromatogram of WT (black) and V60E (red) puriﬁed after
incubation with lipids. The amount of protein injected was 31 lg for WT and 84 lg for V60E. The elution volumes for blue dextran (V0) and the column bed volume (Vc) are
indicated by arrows. The black (WT) and red (V60E) dashed lines correspond to the elution peaks not incubated with liposomes, i.e. the water-soluble form. The absorbance
ﬂuctuations observed at 20 ml are related to the changes in conductivity at Vc. (D) SDS–PAGE of the peaks in panel C. The amount protein in each well corresponds to
2.6 ng of protein. (E) Plot representing Dp vs. p0 values extracted frommonolayer experiments. Fitting a linear equation to the data points gives the value for pc (intercept at
y = 0). Inset: surface pressure kinetic measurements of WT (black) and V60E (red) from where the values for Dp and p0 were extracted. The color code for each protein is
shown in panel B.
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ate lytic activity exhibited by V60R and V60K (Figs. 2A, 3A and B).
Again, this inhibition is not due to lack of binding (Fig. 3E).
In the case of V60F, the introduction of a bulky phenylalanine
might add steric clashes to the protomer–protomer interaction
that result in a 24% reduction in the number of oligomers formed(Supplementary Fig. 1A and Table 1) and an intermediate perme-
abilizing activity (Figs. 2A, 3A and B).
The oligomerization mechanism of FraC (and actinoporins in
general) is rather simple when compared to other PFT where large
rearrangements take place [4,6,28]. Protomer–protomer interac-
tions in b-PFT and cytolysin A commonly involve large interfaces
Table 1
Parameters extracted from the behavior of the toxins in red blood cells and model membranes of SM:PC (1:1).
Protein Hemolysisa Activity on LUVsb SEC analysisc Monolayersd
HC50 (nM) Leakage (%) C50 (lM) Oligomer (%) Monomers (%) pc (mN/m)
WT 2.4 ± 0.3 86 ± 2 0.29 ± 0.01 86 14 36 ± 1.1
V60E 67.6 ± 6.9 0 ± 1 4.42 ± 0.26 19 81 31 ± 0.1
V60R 18.0 ± 4.3 32 ± 3 0.85 ± 0.08 74 26 31 ± 0.6
V60K 13.8 ± 0.7 36 ± 2 1.18 ± 0.36 76 24 32 ± 1.4
V60F 16.7 ± 4.1 32 ± 2 0.94 ± 0.11 65 35 29 ± 2
The values correspond to the means of two or three independent measurements ± their standard deviations.
a Refer to Fig. 2A.
b Refer to Fig. 3A and B. Leakage values correspond to a protein concentration of 0.67 lM.
c Refer to Fig. 3C and Fig. 1 in the supplementary information.
d Refer to Fig. 3D.
Fig. 4. Isothermal titration calorimetry of the toxin-lipid interaction. Thermal titration of WT (43 lM) (A) and V60E (51 lM) (B) with LUV of SM:PC (1:1). The top panel
corresponds to the titration kinetics and the bottom panel to the binding isotherm. The concentration of lipid in the syringe was 16.2 mM in panel A and 15.5 mM in panel B.
The molar ratio refers to lipid/protein. For the thermodynamic parameters refer to the text.
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trostatic interactions predominate [4,7,28]. In contrast, in FraC the
contact surfaces involved in protein–protein interactions are rather
small (8% of the buried surface per monomer) [9] and might com-
promise the stability of the oligomer. To compensate for this
apparent lack of stability, actinoporins might have evolved solvent
exposed residues like Val60 that create patches with high shape
complementarity at the protein–protein interface. These regions
represent hot-spots that govern protein assembly [29] and the
introduction of mutations at this position not only hinders protein
assembly but its overall afﬁnity for membranes as well (Fig. 4).
In summary, oligomerization of proteins might have evolved as
an adaptation to associate with hydrophobic media following a
favorable energetic pathway. For monomeric proteins, the inser-
tion of b-hairpins or amphipathic a-helices across the membrane
would be costly in energetic terms. The development of alternative
cooperative strategies [30] would help to promote the formation of
stable water-ﬁlled pathways across the lipid milieu.Acknowledgments
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